scholarly journals Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

2019 ◽  
Vol 37 (9) ◽  
pp. 1177-1193 ◽  
Author(s):  
Thomas E. Delea ◽  
Xinke Zhang ◽  
Jordan Amdahl ◽  
Diana Boyko ◽  
Franziska Dirnberger ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Lymphoblastic Leukemia ◽  
The United States ◽  
Adult Patients ◽  
Cell Precursor ◽  
Inotuzumab Ozogamicin

scholarly journals Economic Burden of Veno-occlusive Disease in Patients With B-cell Acute Lymphoblastic Leukemia in the United States

2018 ◽  
Vol 40 (10) ◽  
pp. 1711-1719.e1 ◽  
Author(s):  
Xinke Zhang ◽  
Xue Song ◽  
Lorena Lopez-Gonzalez ◽  
Krutika Jariwala-Parikh ◽  
Vadim Romanov ◽  
...  
Keyword(s):  
United States ◽  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Economic Burden ◽  
Lymphoblastic Leukemia ◽  
The United States ◽  
Occlusive Disease ◽  
Cell Acute Lymphoblastic Leukemia
Sign in / Sign up

Export Citation Format

Share Document